Abstract:8569 Background: With the wide use of CT for lung cancer screening and diagnosis, detection of pulmonary nodules increases drastically. Brock malignancy risk scoring is a validated risk prediction model for distinguishing malignant nodules, but it only provides a snapshot without incorporating the dynamic changes of lung nodules. Our study tested the performance of Brock malignancy risk scoring system in patients with persistent lung nodules. Methods: We prospectively studied a cohort of 304 patients with persistent lung nodules (at least 2 CT scans, 3 months apart with no evidence of shrinkage) who were under management at MD Anderson Cancer Center from 11/28/2018 to 12/14/2022. These lung nodules were assessed by radiologists with Brock full model. These patients were followed up routinely and subjected to biopsy as determined by treating physicians. The area under the receiver operating characteristic curve (AUC) and the optimal cut-off of Brock model was studied. Additionally, we studied another cohort with 130 patients with histologically confirmed lung cancer. We retrospectively reviewed the CT or PET/CT scans and assessed the corresponding persistent lung nodules as defined above prior to the cancer diagnosis. We explored the correlations among nodule characteristics, demographic factors and Brock cancer risk scores. Cox proportional hazards model was built for multivariate analysis. Results: The median follow-up time for the prospective cohort was 337 days and 40 of the 304 patients (13.16%) were diagnosed with lung cancer with a median lung cancer-free survival of 228 days. The mean risk score was 24.20% (0.12%-62.86%) for histologically confirmed malignant vs 11.01% (0.07%-61.84%) for the remaining lung nodules (P < 0.001). Of note, 4 of 46 (8.70%) patients with persistent lung nodules of risk scores between 5%-10% and 8 of 134 (5.97%) patients with risk score < 5% were diagnosed with lung cancer. The AUC for Brock model was 0.72 and the optimal cut-off value is 10.64% (sensitivity: 0.702, specificity:0.677). Among the retrospective cohort of 130 lung cancer patients (82.3% adenocarcinoma, 13.1% squamous cell carcinoma and 4.6% others), the predicted risk score ranged from 0.09% to 85.82%, including 33.85% of patients with risk score < 10% and 26.15% of patients with predicted risk score < 5%. The risk score was not correlated with age, sex, race, ethnicity, smoking history, family history of lung cancer, emphysema, nodule types or locations. The low-risk patients had a longer median cancer-free time (P = 0.001). Conclusions: Persistency is an important risk factor for malignant lung nodules. Using Brock criteria, a substantial proportion of lung nodules with true malignant potential can be overlooked because of predicted “low risk”. Improved prediction models incorporating the dynamic changes of lung nodules are warranted to guide early diagnosis of lung cancer.

Will That Pulmonary Nodule Become Cancerous? A Risk Prediction Model for Incident Lung Cancer

The probability of lung cancer in patients with incidentally detected pulmonary nodules detected via low-dose computed tomography screening in China.

Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population

Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy

Using a risk model for probability of cancer in pulmonary nodules

Predicting Lung Cancer Risk of Incidental Solid and Subsolid Pulmonary Nodules in Different Sizes.

Cancer risk assessment in patients with persistent pulmonary nodules and its correlation with cancer-free survival.

Approaches to lung nodule risk assessment: clinician intuition versus prediction models

Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial

Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT

Solitary Pulmonary Nodules: Clinical Prediction Model Versus Physicians

A Predictive Model Integrating AI Recognition Technology and Biomarkers for Lung Nodule Assessment

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules

Lung cancer risk prediction models based on pulmonary nodules: A systematic review

A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodules.

Predictive Model for the Diagnosis of Benign/malignant Small Pulmonary Nodules

The Utility of Nodule Volume in the Context of Malignancy Prediction for Small Pulmonary Nodules

Solitary pulmonary nodules prediction for lung cancer patients using nomogram and machine learning

Risk of Malignancy in Incidentally Detected Lung Nodules in Patients Aged Younger Than 35 Years

An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans.

The Pulmonary Nodule "discovered" by Pneumonia: a Case Report.